Lesanto Laboratories is a finished-dose manufacturer based in India. It appears in 90 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with NAFDAC (NG), FDA (GH) and MINSA (CR). Its GMP standing is certified by NAFDAC (NG). Customs aggregates show $41K of exports covering 5 molecules to 2 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Thane, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NAFDAC (NG) | 80 | 2 |
| FDA (GH) | 5 | None |
| MINSA (CR) | 5 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $41K | 2 |
| 2024 | Not reported | $31K | 2 |
| 2023 | Not reported | $219K | 4 |
| 2022 | Not reported | $9K | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Lesanto Laboratories, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.